Core Viewpoint - Shenzhen Great Wall Development Technology Co., Ltd. has announced the achievement of the first exercise condition for the stock option incentive plan initiated in 2022, allowing eligible participants to exercise their options [1][2][7]. Summary by Sections Incentive Plan Approval and Conditions - The company held meetings on June 13, 2025, where the board approved the achievement of the first exercise condition for the stock option incentive plan [1][2]. - The plan allows for the exercise of 11.476 million stock options at a price of 10.94 yuan per share [1][13]. Performance Metrics - The company's net asset cash return rate (EOE) for 2023 was 13.52%, exceeding the performance assessment requirement of 13.00% [10][11]. - The net profit compound growth rate for 2023 was also above the required 10.00% [10][11]. Eligible Participants and Options - A total of 369 individuals are eligible to exercise their options, with the total number of options available for exercise being 11.476 million, which represents 0.74% of the company's total share capital [13][19]. - The exercise of options is subject to individual performance assessments, with 363 individuals meeting the performance criteria [12][19]. Adjustments and Changes - The initial number of participants was adjusted from 401 to 396 due to five employees leaving the company [5][14]. - The total number of options granted was reduced from 46.8176 million to 46.5576 million, with the first grant quantity adjusted from 38.12 million to 37.86 million [5][14]. Financial Impact and Management - The exercise of options is not expected to significantly impact the company's financial status or operational results [17][18]. - Funds raised from the exercise will be used to supplement the company's working capital [18]. Compliance and Legal Opinions - The company has obtained necessary approvals and authorizations for the exercise of options, complying with relevant regulations [20][21]. - The independent financial advisor confirmed that all conditions for the exercise of options have been met [20][21].

国浩律师（深圳）事务所 关于 深圳长城开发科技股份有限公司 第一个行权期行权条件成就、注销部分股票期权 及调整行权价格等事项 之 法律意见书 深圳市深南大道 6008 号特区报业大厦 24、31、41、42 层 邮编：518034 电话/Tel: (+86)(755) 8351 5666 传真/Fax: (+86)(755) 8351 5333 网址/Website: http://www.grandall.com.cn 国浩律师（深圳）事务所 法律意见书 GLG/SZ/A6493/FY/2025-681 致：深圳长城开发科技股份有限公司 国浩律师（深圳）事务所（以下简称"本所"）依据与深圳长城开发科 技股份有限公司（以下简称"公司"、"深科技"）签署的《专项法律服务委 托合同》，担任深科技 2022 年股票期权激励计划（以下简称"本次激励计 划"、"本激励计划"）的专项法律顾问。 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管 理办法》（以下简称"《管理办法》"）等有关法律、法规和规范性文件以 及《深圳长城开发科技股份有限公 ...

证券代码：603659 证券简称：璞泰来 公告编号：2025-044 上海璞泰来新能源科技股份有限公司 ? 2022 年激励计划限制性股票回购数量：766,296 股 一、相关激励计划已履行的相关程序 于公司<2022 年股票期权与限制性股票激励计划（草案）>及其摘要的议案》、 关于注销部分股票期权及调整股票期权行权价格、调整 限制性股票回购价格并回购注销部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 2022 年激励计划股票期权注销数量：5,280,900 份 ? 2025 年激励计划股票期权行权价格由 15.43 元/股，调整为 15.26 元/ 股 ? 2022 年激励计划限制性股票回购价格由 23.36 元/股，调整为 23.19 元/ 股 《关于公司<2022 年股票期权与限制性股票激励计划实施考核管理办法>的议 案》、《关于提请股东大会授权董事会办理股权激励相关事宜的议案》，关联董 事韩钟伟先生已回避表决，公司独立董事对本次激励计划及其他相关议案发表了 同意的独立意见。 于 ...

Core Points - The company has completed the registration of the reserved stock options under the 2024 stock option incentive plan, granting a total of 3.98 million stock options to 29 eligible participants [1][2]. Stock Option Grant Details - The grant date for the reserved stock options is set for April 15, 2025, with the registration completion date on June 13, 2025 [1]. - The total number of reserved stock options granted is 3.98 million, with an exercise price of 7.46 yuan per share [1][2]. - The stock options represent 0.78% of the company's total share capital [2]. Exercise Conditions - The stock options have a maximum validity period of 60 months, with specific exercise periods defined [3]. - The first exercise period allows for 50% of the options to be exercised 12 months after the grant date, and the second exercise period allows for the remaining 50% to be exercised 24 months after the first period [4]. - If performance targets are not met, the options will be canceled [4]. Performance Targets - The performance targets for the first exercise period require a net profit of no less than 70 million yuan for 2025, and for the second period, a net profit of no less than 100 million yuan for 2026 [4]. - The exercise ratio is contingent on the achievement of these performance targets, with a scale from 0% to 100% based on performance completion [4]. Personal Performance Evaluation - Individual performance evaluations will determine the exercise ratio for each participant, categorized into four levels (A, B, C, D) with corresponding coefficients [5]. - The actual number of options that can be exercised by an individual cannot exceed their planned exercise amount for the year [5]. Financial Impact - The company will account for the stock options in accordance with relevant accounting standards, estimating the impact on financial results over the years 2025 to 2027 [6]. - The estimated cost of the stock options will be adjusted based on the number of eligible participants and performance metrics [6].

之 法律意见书 二〇二五年六月 上海君澜律师事务所 关于 诺德新材料股份有限公司 调整 2025 年股票期权激励计划 及向激励对象首次授予股票期权 上 海 君 澜 律 师 事 务 所 法律意见书 上海君澜律师事务所 关于诺德新材料股份有限公司 调整 2025 年股票期权激励计划 及向激励对象首次授予股票期权之 法律意见书 致：诺德新材料股份有限公司 上海君澜律师事务所（以下简称"本所"）接受诺德新材料股份有限公司 （以下简称"公司"或"诺德股份"）的委托，根据《上市公司股权激励管理 办法》（以下简称"《管理办法》"）及《诺德新材料股份有限公司 2025 年股 票期权激励计划》（以下简称"《激励计划》"或"本次激励计划"）的规定， 就诺德股份调整本次激励计划及向激励对象首次授予股票期权相关事项（以下 简称"本次调整及授予"）出具本法律意见书。 对本法律意见书，本所律师声明如下： （一）本所律师依据《中华人民共和国证券法》《律师事务所从事证券法 律业务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及 本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵 循了勤勉尽责和诚实信用原则，进 ...

Group 1 - The core point of the announcement is the approval of adjustments to the stock option incentive plan, including changes to the exercise price and conditions for granting options [1][2][3] - The supervisory board held its second temporary meeting in 2025, where all members confirmed the authenticity and completeness of the disclosed information [1] - The board approved the adjustment of the exercise price for the stock option incentive plan, ensuring compliance with relevant regulations and no harm to shareholder interests [1][2] Group 2 - The supervisory board confirmed that the conditions for granting the third exercise period of the stock option incentive plan have been met, allowing 32 incentive participants to exercise their options [2] - The board also approved the cancellation of certain stock options, stating that this action complies with regulations and does not harm shareholder interests [3]

诺德新材料股份有限公司董事会薪酬与考核委员会 关于公司 2025 年股票期权激励计划调整及 首次授予部分激励对象名单（授予日）的核查意见 诺德新材料股份有限公司（以下简称"公司"）公司董事会薪酬与考核委员 会根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以 下简称"《管理办法》"）等有关法律法规以及《公司章程》、《诺德新材料股 份有限公司 2025 年股票期权激励计划（草案）》（以下简称"《激励计划（草 案）》"）的规定，对公司 2025 年股票期权激励计划（以下简称"本次激励计 划"）的调整内容、拟首次授予部分激励对象名单（授予日）进行了核查，发表 核实意见如下： 励计划首次授予部分激励对象人员名单与公司 2025 年第一次临时股东会批准的 《诺德新材料股份有限公司 2025 年股票期权激励计划（草案）》规定的激励对 象相符，激励对象包括公司（含子公司，下同）任职的董事、高级管理人员、中 层管理人员及技术、业务骨干，不包含独立董事、单独或合计持有公司 5%以上 股份的股东或实际控制人及其配偶、父母、子女。公司对本次 ...

《证券日报》 上披露的相关公告。 经中国证券登记结算有限责任公司深圳分公司审核确认，公司上述股票期权注 销事宜已于 2025 年 6 月 12 日办理完毕。 证券代码：002241 证券简称：歌尔股份 公告编号：2025-051 歌尔股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 歌尔股份有限公司(以下简称"公司")于 2025 年 6 月 4 日召开了第六届董事 会第二十七次会议及第六届监事会第二十二次会议，审议通过了《关于调整 2023 年 股票期权激励计划预留授予部分激励对象名单及授予数量并注销部分股票期权的议 案》， 同意公司注销 52 名激励对象持有的已获授但不具备行权条件的合计 112.76 万 份股票期权。具体内容详见公司于 2025 年 6 月 5 日在信息披露媒体巨潮资讯网 http://www.cninfo.com.cn、 《证券时报》 《中国证券报》 《上海证券报》 相关ETF 消费电子ETF (产品代码：159732) ★ 跟踪：国证消费电子主题指数 近五日涨跌: -1.02% 公司本次注销股票期权事项符合《上市公司股权激 ...

Core Viewpoint - The legal opinion letter issued by Shanghai Dongfang Huayin Law Firm confirms that Zhejiang Kang En Bei Pharmaceutical Co., Ltd. has complied with relevant laws and regulations regarding the adjustment of the exercise price for its 2022 stock option incentive plan [1][8]. Group 1: Company Qualifications - The company is a legally established joint-stock company listed on the Shanghai Stock Exchange, with a total share capital of 137.2 million shares, including 40 million A-shares [3]. - The company does not fall under any prohibitive conditions for implementing stock incentives as outlined in the Management Measures [4]. Group 2: Approval and Authorization - The company has completed the necessary approval and authorization procedures for adjusting the exercise price of the stock options under the 2022 incentive plan, in accordance with the Management Measures and the incentive plan [5][8]. Group 3: Adjustment Details - The exercise price for the stock options has been adjusted from 3.78 yuan to 3.63 yuan per share for the first grant, and from 5.07 yuan to 4.92 yuan per share for the reserved grant, following the company's profit distribution plan [6][8].

Group 1 - The company held its third supervisory board meeting on June 13, 2025, with all three supervisors present, confirming the legality and validity of the meeting and its resolutions [1][2] - The supervisory board approved adjustments to the 2025 Stock Option Incentive Plan, stating that the adjustments comply with relevant laws and regulations, and do not harm the interests of the company and its shareholders [1][2] - The board agreed to set June 13, 2025, as the grant date for the stock options, with a grant price of RMB 18.86 per share, confirming that the conditions for the initial grant have been met [2]